GLP-1 Medication Cost: What You Pay In 2026

Professional () hero image with 'GLP-1 Medication Cost' in crisp white on a deep teal semi-transparent panel, centered with

Last updated: October 1, 2026

Table of Contents - [Open] ➨

Quick Answer

GLP-1 medication cost ranges widely in 2026, from roughly $50 per month for eligible Medicare beneficiaries to over $1,300 per month at full list price without insurance. The price you pay depends on your insurance coverage, which drug you use, whether you qualify for manufacturer savings programs, and whether you choose a brand-name or compounded option.

Key Takeaways

Brand-name Ozempic lists at about $1,027 per month and Wegovy at about $1,349 per month without insurance in 2026 [5]
Self-pay patients can access Wegovy injections for roughly $199 to $349 per month and Zepbound for about $299 to $449 per month through manufacturer channels [8]
Oral GLP-1 options and promotional tablet programs start near $149 per month for self-pay patients in 2026 [8]
Medicare’s GLP-1 Bridge program (July 2026 through December 2027) caps eligible beneficiaries at a $50 monthly copay for covered drugs [3][4]
Only about 26 out of roughly 300 Marketplace insurance carriers cover GLP-1 drugs specifically for obesity in 2026 [6]
Manufacturer savings cards can bring costs down to as little as $25 per month for commercially insured patients [8]
Compounded semaglutide and tirzepatide offer lower-cost alternatives, though FDA oversight differs from brand-name products
Novo Nordisk has announced list-price cuts of up to 50% for Wegovy and 34% for Ozempic, effective in 2027 [8]
A generic version of liraglutide (an older daily GLP-1) is now available, with monthly costs as low as about $221 with discount coupons [10]
Comparing pharmacies and using GoodRx-style coupons can meaningfully reduce out-of-pocket costs

What Is GLP-1 Medication and How Does It Work

GLP-1 medications are a class of prescription drugs that mimic a hormone called glucagon-like peptide-1, which your body naturally releases after eating. They work by slowing stomach emptying, reducing appetite signals in the brain, and stimulating insulin release from the pancreas. The result is lower blood sugar, reduced hunger, and, for many people, significant weight loss.

The most widely used GLP-1 drugs in 2026 include:

Semaglutide (brand names: Ozempic for diabetes, Wegovy for weight loss), weekly injectable or oral tablet
Tirzepatide (brand names: Mounjaro for diabetes, Zepbound for weight loss), weekly injectable; also a dual GIP/GLP-1 agonist
Liraglutide (brand name: Victoza for diabetes, Saxenda for weight loss), daily injectable; a generic version is now available [10]

Originally developed for type 2 diabetes, these drugs have since been approved for chronic weight management, and research continues to expand their use into cardiovascular and other metabolic conditions [7]. If you want a deeper look at which option may work fastest, see this guide on which GLP-1 medication acts quickest and what to expect.

How Much Does GLP-1 Medication Cost Without Insurance

Without insurance, GLP-1 medication cost is high by almost any measure. The official list prices in 2026 are:

Ozempic: approximately $1,027.51 per month [5]
Wegovy (injection): approximately $1,349.02 per month [5]
Zepbound (injection): list price in a similar range to Wegovy

However, list prices are not what most self-pay patients actually pay. Manufacturers have introduced direct-to-consumer and cash-pay programs that bring costs down substantially:

Wegovy injections: roughly $199 to $349 per month depending on dose [8]
Zepbound injections: roughly $299 to $449 per month through Lilly’s own channels [8]
Oral GLP-1 tablets (including Wegovy tablets at lower doses): as low as $149 per month for self-pay patients [8]

One large direct-to-consumer platform launched in early 2026 reported observed cash-pay prices of about $350 per month for injectable semaglutide and about $346 per month for tirzepatide [10]. These are real prices available to patients today, though they can change.

For a detailed breakdown of what semaglutide specifically costs through online channels, see how much semaglutide costs in 2026.

GLP-1 Medication Cost Comparison: Ozempic vs. Wegovy vs. Mounjaro vs. Zepbound

These four drugs dominate the GLP-1 market, but they serve slightly different purposes and carry different price tags.

Drug	Brand	Primary Use	List Price/Month	Self-Pay Range
Semaglutide	Ozempic	Type 2 diabetes	~$1,027 [5]	~$350 (DTC) [10]
Semaglutide	Wegovy	Weight loss	~$1,349 [5]	$199,$349 [8]
Tirzepatide	Mounjaro	Type 2 diabetes	Similar to Wegovy	~$346 (DTC) [10]
Tirzepatide	Zepbound	Weight loss	Similar to Wegovy	$299,$449 [8]

Key distinction: Ozempic and Mounjaro are FDA-approved for diabetes. Wegovy and Zepbound are FDA-approved for chronic weight management. Insurers often cover the diabetes versions more readily, which is why some patients are prescribed Ozempic off-label for weight loss, though coverage rules vary. For a side-by-side cost analysis of specific options, see this GLP-1 semaglutide and compounded tirzepatide cost breakdown.

Does Insurance Cover GLP-1 Medication

Insurance coverage for GLP-1 drugs is inconsistent and often depends on the diagnosis on the prescription. For diabetes, coverage is relatively common. For obesity or weight loss alone, coverage is far more limited.

Key facts for 2026:

Out of roughly 300 Marketplace insurance carriers, only about 26 offered coverage for GLP-1 drugs specifically to treat obesity [6]
About 7% of people with commercial insurance, nearly 13 million individuals, had no coverage for any GIP/GLP-1 agonist used for weight loss [6]
Many employer plans explicitly exclude weight-loss uses, so patients may only receive coverage when the drug is prescribed for diabetes [6]
Some insured patients pay over $1,400 per month when coverage is denied or limited for weight-loss indications [10]

Medicare: The Medicare GLP-1 Bridge program, running from July 1, 2026, through December 31, 2027, gives eligible Part D beneficiaries access to select GLP-1 drugs for weight management at a fixed $50 monthly copay [3][4]. Covered drugs include Wegovy (injection and tablet), Foundayo tablets, and certain Zepbound pens [3]. This is a major shift, since Medicare historically did not cover weight-loss drugs.

Medicaid: Coverage varies by state. Some states cover GLP-1s for diabetes but not obesity.

If you’re unsure whether your plan covers Wegovy specifically, this Wegovy pill cost without insurance guide walks through what to expect.

Why Is GLP-1 Medication So Expensive

GLP-1 medications are expensive primarily because they are still under patent protection, require complex manufacturing, and face strong demand with limited competition. Manufacturers set list prices based on what the market and payers will bear, and with no generic alternatives for the newest weekly injectables, there is little downward pricing pressure yet [7].

Additional factors driving up GLP-1 medication cost:

R&D investment: Developing and trialing these drugs cost billions of dollars
Biologic manufacturing: Unlike a simple pill, GLP-1 injectables require sophisticated production processes
Surging demand: Millions of new prescriptions annually create supply and pricing pressure [7]
Limited competition: Only a handful of manufacturers produce the leading weekly agents
Payer resistance: When insurers don’t cover a drug, manufacturers face less negotiating pressure to lower list prices

The good news: Novo Nordisk has announced it will cut Wegovy’s list price by up to 50% (to about $675 per month) and Ozempic’s by about 34% in 2027 [8]. These cuts have not taken effect yet as of October 2026, but they signal a turning point.

How to Get GLP-1 Medication Cheaper

There are several practical ways to reduce GLP-1 medication cost, and using more than one strategy at a time often produces the biggest savings.

Step 1: Check your insurance coverage first. Call your insurer and ask specifically whether your plan covers GLP-1 drugs for your diagnosis (diabetes vs. obesity). The answer changes what you pay dramatically.

Step 2: Use manufacturer savings cards. Lilly’s savings card for Zepbound can bring costs down to as little as $25 per month for commercially insured patients [8]. Novo Nordisk offers similar programs for Wegovy and Ozempic.

Step 3: Compare pharmacy prices. The same prescription can vary by hundreds of dollars between pharmacies. Tools like GoodRx can surface lower prices at local and mail-order pharmacies. See this guide on GoodRx Mounjaro coupons and semaglutide prescriptions without insurance for specifics.

Step 4: Explore telehealth platforms. Several telehealth services offer GLP-1 prescriptions with competitive cash-pay pricing, sometimes bundled with physician visits and monitoring.

Step 5: Consider compounded semaglutide or tirzepatide. Compounding pharmacies can prepare these medications at lower prices. Costs through compounding pharmacies can be substantially below brand-name list prices, though you should verify the pharmacy’s accreditation. For a full breakdown, see this compounding pharmacy semaglutide cost breakdown.

Step 6: Ask about oral options. Oral GLP-1 tablets have a lower entry price, some start near $149 per month for self-pay patients [8], and may be appropriate for patients earlier in treatment.

Cheapest GLP-1 Medication Options in 2026

The most affordable GLP-1 options available right now fall into three categories:

Generic liraglutide: The first generic version of an older GLP-1 (daily injectable) is now available, with monthly costs as low as about $221 with discount coupons [10]. It’s not as convenient as weekly injectables, but it’s a legitimate lower-cost entry point.
Oral GLP-1 tablets: Wegovy tablets at lower doses have been offered around $149 per month for self-pay patients, with higher doses moving toward $199 [8].
Compounded semaglutide or tirzepatide: Available through accredited compounding pharmacies, often via telehealth prescriptions. Prices vary but can be meaningfully lower than brand-name options. See a detailed tirzepatide compounding pharmacy cost guide for current pricing.

Choose compounded if: You cannot afford brand-name pricing, your insurance doesn’t cover GLP-1s for weight loss, and you’re working with a licensed prescriber who can monitor your progress.

Choose brand-name if: You have insurance coverage or a manufacturer savings card, you want the full clinical trial data behind the exact formulation, or you’re enrolled in the Medicare Bridge program.

GLP-1 Medication Side Effects and Risks

GLP-1 medications are generally well-tolerated, but side effects are common, especially when starting or increasing the dose.

Most common side effects:

Nausea (most frequently reported, especially early on)
Vomiting
Diarrhea or constipation
Stomach pain or bloating
Fatigue

Less common but serious risks:

Pancreatitis (inflammation of the pancreas)
Gallbladder disease
Increased heart rate
Possible thyroid tumors (seen in animal studies; patients with a personal or family history of medullary thyroid carcinoma should not use these drugs)
Hypoglycemia, particularly when combined with other diabetes medications

Most side effects are dose-dependent and tend to improve over time. Starting at a low dose and titrating slowly is the standard approach to minimizing GI discomfort [2].

Who Should Not Take GLP-1 Medication

GLP-1 medications are not appropriate for everyone. Your prescriber will screen for contraindications before starting treatment.

Do not use GLP-1 medications if you have:

A personal or family history of medullary thyroid carcinoma (MTC)
Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
A history of serious hypersensitivity to the drug or its ingredients
Severe gastrointestinal disease (e.g., gastroparesis)

Use with caution if you have:

A history of pancreatitis
Kidney or liver disease
Are pregnant or breastfeeding (safety data is limited; most guidelines advise against use)
Are taking insulin or other diabetes medications that can cause low blood sugar

Always discuss your full medication list with your prescriber. GLP-1 drugs can interact with other medications, particularly those that also affect blood glucose [2].

GLP-1 Medication for Weight Loss vs. Diabetes

The same active ingredient can be approved for two different conditions, and this distinction matters enormously for insurance coverage and GLP-1 medication cost.

For diabetes: Ozempic (semaglutide) and Mounjaro (tirzepatide) are FDA-approved. Insurance coverage is broader, and prior authorization is more commonly granted.
For weight loss: Wegovy (semaglutide) and Zepbound (tirzepatide) are FDA-approved. Coverage is far more restricted, and many plans exclude this indication entirely [6].

Clinically, the drugs work the same way regardless of indication. The difference lies in the approved dosing range and the indication on the label. Some patients are prescribed the diabetes version off-label for weight loss, which can affect coverage. For a comprehensive look at which option works best for weight loss specifically, see which GLP-1 medication works best for weight loss.

GLP-1 Medication Coupon and Discount Programs

Several programs can reduce what you pay at the pharmacy, and they’re worth checking before filling any prescription.

Manufacturer savings programs:

Lilly (Zepbound/Mounjaro): Savings card for commercially insured patients, as low as $25/month [8]
Novo Nordisk (Wegovy/Ozempic): Similar savings card programs; self-pay promotional prices available through manufacturer channels [8]

Third-party discount tools:

GoodRx, RxSaver, and similar platforms aggregate pharmacy prices and coupons
Discount prices can vary significantly between pharmacies for the same drug

Medicare Bridge program:

Eligible Medicare Part D beneficiaries pay a fixed $50 monthly copay through December 2027 [3][4]

Telehealth subscription platforms:

Some platforms bundle the prescription, physician oversight, and medication into a monthly fee that can be competitive with cash-pay brand prices

Common mistake: Many patients assume their insurance covers GLP-1s and skip the savings card enrollment. If your plan has a high deductible or excludes weight-loss drugs, a manufacturer card or discount program may save you hundreds of dollars per month.

Conclusion

GLP-1 medication cost in 2026 is genuinely high at list price, but the actual amount most patients pay is far more variable than the sticker shock suggests. Official list prices for Ozempic and Wegovy exceed $1,000 per month, but self-pay programs, manufacturer savings cards, telehealth platforms, oral options, compounded alternatives, and the new Medicare Bridge program have created real pathways to access for a much wider range of patients.

Actionable next steps:

Call your insurer today and ask specifically whether your plan covers GLP-1 drugs for your diagnosis. Get the answer in writing if possible.
Ask your prescriber about manufacturer savings programs before your first fill. A savings card can cut your monthly cost dramatically if you have commercial insurance.
Compare prices across pharmacies using GoodRx or a similar tool. The same prescription can vary by $200 or more between pharmacies.
If you’re on Medicare, check whether you qualify for the GLP-1 Bridge program at medicare.gov for a $50 monthly copay [3].
If cost remains a barrier, ask your prescriber about oral GLP-1 options, compounded alternatives, or the generic liraglutide option, which can bring monthly costs under $250.

The pricing landscape is shifting. With list-price cuts coming in 2027 and more oral and generic options entering the market, access should improve. But right now, the patients who pay the least are the ones who actively compare options rather than accepting the first price they see.

FAQ

How much does GLP-1 medication cost per month in 2026?
It depends on the drug and your coverage. List prices run from about $1,027 (Ozempic) to $1,349 (Wegovy) per month, but self-pay programs bring injectable costs to roughly $199 to $449 per month, and oral options start near $149 per month for self-pay patients [5][8].

Is GLP-1 medication covered by Medicare?
As of July 1, 2026, eligible Medicare Part D beneficiaries can access select GLP-1 drugs for weight management through the Medicare GLP-1 Bridge program for a fixed $50 monthly copay. This program runs through December 31, 2027 [3][4].

What is the cheapest GLP-1 medication available?
Generic liraglutide (a daily injectable) is currently the lowest-cost FDA-approved GLP-1, with monthly costs as low as about $221 using discount coupons [10]. Oral GLP-1 tablets and compounded semaglutide are also lower-cost options.

Will GLP-1 drug prices drop in 2027?
Yes. Novo Nordisk has announced plans to cut Wegovy’s list price by up to 50% and Ozempic’s by about 34% in 2027, bringing both to approximately $675 per month [8]. These cuts have not yet taken effect as of October 2026.

Does health insurance cover GLP-1 medication for weight loss?
Coverage is limited. Only about 26 out of roughly 300 Marketplace carriers cover GLP-1 drugs specifically for obesity in 2026. Coverage is more common when the drug is prescribed for type 2 diabetes [6].

Can I use a coupon or savings card for GLP-1 medication?
Yes. Manufacturer savings cards (from Lilly and Novo Nordisk) can reduce costs to as little as $25 per month for commercially insured patients. Third-party tools like GoodRx can also lower cash-pay prices at participating pharmacies [8].

What is compounded semaglutide and is it cheaper?
Compounded semaglutide is a version of the active ingredient prepared by a compounding pharmacy, typically at a lower cost than brand-name Ozempic or Wegovy. It requires a prescription and the quality depends on the pharmacy’s accreditation. See a detailed compounded vs. brand semaglutide pros, cons, and costs comparison for more.

How long do I need to take GLP-1 medication?
GLP-1 drugs are typically used long-term. Clinical data shows that stopping the medication often leads to weight regain. Most prescribers treat it as an ongoing therapy rather than a short-term course, which makes monthly cost a critical factor in any treatment decision [2].

Are GLP-1 medications safe long-term?
The longest clinical trials run several years and show a generally favorable safety profile for most patients. Serious risks (thyroid tumors, pancreatitis) are rare but real, and regular monitoring is recommended [2].

What happens if I can’t afford GLP-1 medication?
Start by checking manufacturer savings programs, the Medicare Bridge program (if eligible), and discount pharmacy tools. If cost remains a barrier, ask your prescriber about oral options, generic liraglutide, or compounded alternatives. Some telehealth platforms also offer bundled pricing that is more affordable than retail.